首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   11223篇
  免费   948篇
  国内免费   303篇
耳鼻咽喉   55篇
儿科学   249篇
妇产科学   84篇
基础医学   3741篇
口腔科学   259篇
临床医学   656篇
内科学   1992篇
皮肤病学   176篇
神经病学   253篇
特种医学   149篇
外国民族医学   1篇
外科学   510篇
综合类   1343篇
预防医学   1136篇
眼科学   60篇
药学   623篇
  2篇
中国医学   536篇
肿瘤学   649篇
  2023年   235篇
  2022年   246篇
  2021年   462篇
  2020年   389篇
  2019年   301篇
  2018年   324篇
  2017年   380篇
  2016年   399篇
  2015年   452篇
  2014年   640篇
  2013年   820篇
  2012年   582篇
  2011年   670篇
  2010年   552篇
  2009年   595篇
  2008年   512篇
  2007年   557篇
  2006年   493篇
  2005年   442篇
  2004年   442篇
  2003年   331篇
  2002年   300篇
  2001年   284篇
  2000年   207篇
  1999年   200篇
  1998年   157篇
  1997年   144篇
  1996年   115篇
  1995年   114篇
  1994年   125篇
  1993年   105篇
  1992年   88篇
  1991年   80篇
  1990年   69篇
  1989年   77篇
  1988年   68篇
  1987年   56篇
  1986年   52篇
  1985年   66篇
  1984年   52篇
  1983年   33篇
  1982年   56篇
  1981年   38篇
  1980年   44篇
  1979年   34篇
  1978年   21篇
  1977年   19篇
  1976年   26篇
  1975年   6篇
  1973年   3篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Vaccine》2022,40(27):3721-3726
We initiated a randomized, placebo-controlled, phase 1/2 trial to evaluate the safety and immunogenicity of the S-268019-b recombinant protein vaccine, scheduled as 2 intramuscular injections given 21 days apart, in 60 randomized healthy Japanese adults. We evaluated 2 regimens of the S-910823 antigen (5 μg [n = 24] and 10 μg [n = 24]) with an oil-in-water emulsion formulation and compared against placebo (n = 12). Reactogenicity was mild in most participants. No serious adverse events were noted. For both regimens, vaccination resulted in robust IgG and neutralizing antibody production at days 36 and 50 and predominant T-helper 1-mediated immune reaction, as evident through antigen-specific polyfunctional CD4+ T-cell responses with IFN-γ, IL-2, and IL-4 production on spike protein peptides stimulation. Based on the interim analysis, the S-268019-b vaccine is safe, produces neutralizing antibodies titer comparable with that in convalescent serum from COVID-19-recovered patients. However, further evaluation of the vaccine in a large clinical trial is warranted.  相似文献   
2.
Specialized pro-resolving mediators (SPMs) are endogenous small molecules produced mainly from dietary omega-3 polyunsaturated fatty acids by both structural cells and cells of the active and innate immune systems. Specialized pro-resolving mediators have been shown to both limit acute inflammation and promote resolution and return to homeostasis following infection or injury. There is growing evidence that chronic immune disorders are characterized by deficiencies in resolution and SPMs have significant potential as novel therapeutics to prevent and treat chronic inflammation and immune system disorders. This review focuses on important breakthroughs in understanding how SPMs are produced by, and act on, cells of the adaptive immune system, specifically macrophages, B cells and T cells. We also highlight recent evidence demonstrating the potential of SPMs as novel therapeutic agents in topics including immunization, autoimmune disease and transplantation.  相似文献   
3.
4.
5.
《Molecular therapy》2022,30(3):1018-1035
  1. Download : Download high-res image (91KB)
  2. Download : Download full-size image
  相似文献   
6.
Waldenström macroglobulinemia (WM) is a rare subtype of non-Hodgkin lymphoma characterized by malignant lymphoplasmacytic cells in the bone marrow (BM). To dissect the pathophysiology of WM, we evaluated clonal cells by mapping of B cell lymphomagenesis with adaptive and innate immune tumor microenvironment (TME) in the BM of WM patients using mass cytometry (CyTOF). In-depth immunophenotypic profiling of WM cells exhibited profound expansion of clonal cells in both unswitched and switched memory B cells and also plasma cells with aberrant expression variations. WM B lymphomagenesis was associated with reduction of most B cell precursors assessed with the same clonally restricted light chain and phenotypic changes. The immune TME was infiltrated by mature monocytes, neutrophils and adaptive T cells, preferentially subsets of effector T helper, effector CTL and effector memory CTL cells that were associated with superior overall survival (OS), in contrast to progenitors of T cells and myeloid/monocytic lineage subsets that were suppressed in WM cohort. Moreover, decrease in immature B and NKT cells was related to worse OS in WM patients. Innate and adaptive immune subsets of WM TME were modulated by immune checkpoints, including PD-1/PD-L1&PD-L2, TIGIT/PVR, CD137/CD137-L, CTLA-4, BTLA and KIR expression. The response of ibrutinib treatment to the reduction of clonal memory B cell was associated with high levels of immature B cells and effector memory CTL cells. Our study demonstrates that CyTOF technology is a powerful approach for characterizing the pathophysiology of WM at various stages, predicting patient risk and monitoring the effectiveness of treatment strategies.  相似文献   
7.
学者们对动脉血管的研究常聚焦在血管内膜动脉粥样硬化(As)斑块的形成,而很少关注血管外膜的免疫反应及其对疾病病程的影响。前期研究发现,老龄的ApoE-/-小鼠动脉外膜出现免疫细胞的有序集聚,形成类似淋巴结的异位淋巴组织,称之为动脉三级淋巴组织(ATLO),其形成对内膜As具有明显的调控作用。ATLO的发现及研究为As的研究指明了新的方向,并为其他疾病状况下三级淋巴组织(TLO)的研究提供了很好的范例。因此,阐明TLO的特点及形成机制对As的防治具有重要的意义,并为其在其他疾病中的临床运用提供坚实的基础。  相似文献   
8.
9.
《Cancer cell》2022,40(6):674-693.e7
  1. Download : Download high-res image (235KB)
  2. Download : Download full-size image
  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号